2 completed, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Keratoconjunctivitis, Vernal: new trials by email Literature Review of Keratoconjunctivitis, Vernal trials Research Report on Keratoconjunctivitis, Vernal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical rVA576 for Treatment of Atopic Keratoconjunctivitis rVA576, Placebo - Keratoconjunctivitis, Atopic, Keratoconjunctivitis, Vernal | Phase 1 / Phase 2 | Terminated | AKARI Therapeutics | 12 | 2019-03-04 | 2025-04-10 |
| Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC) tacrolimus, cyclosporins - Keratoconjunctivitis, Vernal | Phase 2 / Phase 3 | Completed | Siriraj Hospital | 24 | 2003-06-01 | 2010-02-12 |
| Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis N-acetyl-aspartyl-glutamate (NAAXIA Sine) - Keratoconjunctivitis, Vernal | Phase 4 | Completed | Laboratoires Thea | 2001-04-01 | 2006-07-27 |
Conjunctivitis, Allergic (3) · Keratoconjunctivitis (1)
Conjunctival Diseases (3) · Conjunctivitis (3) · Eye Diseases (3) · Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Corneal Diseases (1) · Keratitis (1)
Cyclosporins (1) · Tacrolimus (1) · isospaglumic acid (1)
AKARI Therapeutics (1) · Laboratoires Thea (1) · Siriraj Hospital (1)
Spain (1) · Thailand (1) · United Kingdom (1)
Pakit Vichyanond, MD (1) · Sajjad Ahmad (1)